Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Vectus Biosystems Limited ( (AU:VBS) ) has shared an update.
Vectus Biosystems Limited has released its Corporate Governance Statement for the period from July 2024 to June 2025, highlighting its adherence to ASX corporate governance principles. The company acknowledges that while it strives to comply with these guidelines, certain recommendations are not feasible due to its size. The Board, supported by various committees, oversees governance, ensuring transparency and accountability in its operations.
More about Vectus Biosystems Limited
Vectus Biosystems Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is committed to adhering to corporate governance principles, guided by the Australian Securities Exchange’s recommendations.
Average Trading Volume: 54,692
Technical Sentiment Signal: Sell
Current Market Cap: A$3.2M
Learn more about VBS stock on TipRanks’ Stock Analysis page.